Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Mar 18;10(6):1257.
doi: 10.3390/jcm10061257.

Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?

Affiliations
Review

Screening for Gestational Diabetes Mellitus in Early Pregnancy: What Is the Evidence?

Lore Raets et al. J Clin Med. .

Abstract

The incidence of gestational diabetes mellitus (GDM) is increasing worldwide. This has a significant effect on the health of the mother and offspring. There is no doubt that screening for GDM between 24 and 28 weeks is important to reduce the risk of adverse pregnancy outcomes. However, there is no consensus about diagnosis and treatment of GDM in early pregnancy. In this narrative review on the current evidence on screening for GDM in early pregnancy, we included 37 cohort studies and eight randomized controlled trials (RCTs). Observational studies have shown that a high proportion (15-70%) of women with GDM can be detected early in pregnancy depending on the setting, criteria used and screening strategy. Data from observational studies on the potential benefit of screening and treatment of GDM in early pregnancy show conflicting results. In addition, there is substantial heterogeneity in age and BMI across the different study populations. Smaller RCTs could not show benefit but several large RCTs are ongoing. RCTs are also necessary to determine the appropriate cut-off for HbA1c in pregnancy as there is limited evidence showing that an HbA1c ≥6.5% has a low sensitivity to detect overt diabetes in early pregnancy.

Keywords: diabetes; early screening; gestational diabetes mellitus; pregnancy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The literature search and selection process.

References

    1. Standards of medical care in diabetes–2013. Diabetes Care. 2013;36(Suppl. 1):S11–S66. doi: 10.2337/dc13-S011. - DOI - PMC - PubMed
    1. Crowther C.A., Hiller J.E., Moss J.R., McPhee A.J., Jeffries W.S., Robinson J.S. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 2005;352:2477–2486. doi: 10.1056/NEJMoa042973. - DOI - PubMed
    1. Landon M.B., Spong C.Y., Thom E., Carpenter M.W., Ramin S.M., Casey B., Wapner R.J., Varner M.W., Rouse D.J., Thorp J.M., Jr., et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N. Engl. J. Med. 2009;361:1339–1348. doi: 10.1056/NEJMoa0902430. - DOI - PMC - PubMed
    1. American Diabetes Association 14. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes–2020. Diabetes Care. 2020;43:S183–S192. doi: 10.2337/dc20-S014. - DOI - PubMed
    1. Hod M., Kapur A., Sacks D.A., Hadar E., Agarwal M., Di Renzo G.C., Roura L.C., McIntyre H.D., Morris J.L., Divakar H. The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: A pragmatic guide for diagnosis, management, and care#. Int. J. Gynecol. Obstet. 2015;131:S173–S211. - PubMed

LinkOut - more resources